Get my own profile
Public access
View all5 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Petra M NederlofNetherlands Cancer Institute NKIVerified email at nki.nl
- Lodewyk WesselsProfessor of Computational Cancer BiologyVerified email at nki.nl
- Alexandra EinerhandVerified email at danone.com
- Hugo M. HorlingsMD PhD, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsVerified email at nki.nl
- Jelle WesselingGroup Leader, Netherlands Cancer InstituteVerified email at nki.nl
- Sabine LinnProfessor of Translational Oncology - Utrecht University; Group leader NKI AmsterdamVerified email at nki.nl
- Marjanka K SchmidtNetherlands Cancer InstituteVerified email at nki.nl
- Nicoline HoogerbruggeHoogleraar erfelijke kanker, medisch specialistVerified email at gen.umcn.nl
- William D. FoulkesProfessor of Oncology, Medicine, and Human Genetics. McGill UniversityVerified email at mail.mcgill.ca
- Harm van TinterenHoofd afdeling Biometrics, Antoni van LeeuwenhoekVerified email at nki.nl
- Elisabeth de VriesProfessor of Medical Oncology, University Medical Center Groningen, Groningen, the NetherlandsVerified email at umcg.nl
- Antoon MoormanDepartment of Medical Biology, AMC, AmsterdamVerified email at amsterdamumc.nl
- Steven NarodCanada Research Chair in Breast Cancer; Director, Familial Breast Cancer Research Unit, WCRIVerified email at wchospital.ca
- Jos JonkersProfessor at Leiden University and group leader at Netherlands Cancer Institute, Oncode InstituteVerified email at nki.nl
- Henne HolstegeAmsterdam UMC, Alzheimer Center, Clinical GeneticsVerified email at vumc.nl
- Lars BullingerCharité University Medicine BerlinVerified email at charite.de
- Jan Dekker (rekkednaj@gmail.com)Pepscan, Lelystad
- Ron M. KerkhovenRetired Associated Scientist, Netherlands Cancer Institute